Aptamers News and Research

RSS
Radioimmunotherapy targeting viral antigens shows potential to treat or prevent viral cancers

Radioimmunotherapy targeting viral antigens shows potential to treat or prevent viral cancers

New tool to identify the molecular signatures of serious diseases

New tool to identify the molecular signatures of serious diseases

Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells

Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells

Cancer cell targeting using multiple aptamers conjugated on nanorods

Cancer cell targeting using multiple aptamers conjugated on nanorods

Aptamers may refine cancer treatment

Aptamers may refine cancer treatment

Aptamer-targeted nanoparticles collect and detect cancer cells

Aptamer-targeted nanoparticles collect and detect cancer cells

Archemix granted two European patents

Archemix granted two European patents

Aptamer-capped nanocrystal quantum dots

Aptamer-capped nanocrystal quantum dots

High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals

High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals

Test strips for the rapid detection of cocaine

Test strips for the rapid detection of cocaine

Low-field magnetic separation of monodisperse Fe3O4 nanocrystals

Low-field magnetic separation of monodisperse Fe3O4 nanocrystals

Modified silicon-based surfaces provide good home to proteins

Modified silicon-based surfaces provide good home to proteins

Built-in blocker - drug and antidote in the same molecule

Built-in blocker - drug and antidote in the same molecule

Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics

Sirna Therapeutics awarded patent covering large-scale synthesis of RNAi-based therapeutics

New cancer detection method

New cancer detection method

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates

Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates

Unique arrays of proteins tethered onto self-assembled DNA nanostructures

Unique arrays of proteins tethered onto self-assembled DNA nanostructures

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)